Literature DB >> 10951600

Natural versus drug-induced resistance in Schistosoma mansoni infection.

R Corrêa-Oliveira1, I R Caldas, G Gazzinelli.   

Abstract

Rodrigo Corrêa-Oliveira, Iramaya Rodrigues Caldas and Giovanni Gazzinelli here focus on the immune response of individuals with natural resistance to schistosomiasis, which differs significantly from that of post-treatment resistant and infected individuals. They suggest that the activation of T helper type 1 (Th1) and Th2 cells is needed for the induction of natural resistance against Schistosoma mansoni infection.

Entities:  

Mesh：

Year:  2000        PMID： 10951600     DOI： 10.1016/s0169-4758(00)01740-3

Source DB:  PubMed          Journal:  Parasitol Today        ISSN： 0169-4758


  32 in total

1.  Morbidity and immune response to natural schistosomiasis in baboons ( Papio anubis).

Authors:  Idle Farah; Andreas Börjesson; Thomas Kariuki; Dorcas Yole; Mbaruk Suleman; Jann Hau; Hans-Erik Carlsson
Journal:  Parasitol Res       Date:  2003-09-18       Impact factor: 2.289

Review 2.  Developing vaccines to combat hookworm infection and intestinal schistosomiasis.

Authors:  Peter J Hotez; Jeffrey M Bethony; David J Diemert; Mark Pearson; Alex Loukas
Journal:  Nat Rev Microbiol       Date:  2010-11       Impact factor: 60.633

Review 3.  The protective role of antibody responses during Mycobacterium tuberculosis infection.

Authors:  F Abebe; G Bjune
Journal:  Clin Exp Immunol       Date:  2009-08       Impact factor: 4.330

Review 4.  Current status of vaccines for schistosomiasis.

Authors:  Donald P McManus; Alex Loukas
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

Review 5.  Development of a schistosomiasis vaccine.

Authors:  Adebayo J Molehin; Juan U Rojo; Sabrina Z Siddiqui; Sean A Gray; Darrick Carter; Afzal A Siddiqui
Journal:  Expert Rev Vaccines       Date:  2016-01-13       Impact factor: 5.217

6.  Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection.

Authors:  Lucia A de Oliveira Fraga; Erika W Lamb; Elizabeth C Moreno; Mitali Chatterjee; Jan Dvořák; Melaine Delcroix; Mohammed Sajid; Conor R Caffrey; Stephen J Davies
Journal:  BMC Immunol       Date:  2010-11-15       Impact factor: 3.615

7.  Cross-reactivity of Schistosoma mansoni cytosolic superoxide dismutase, a protective vaccine candidate, with host superoxide dismutase and identification of parasite-specific B epitopes.

Authors:  Claudia Carvalho-Queiroz; Rosemary Cook; Ching C Wang; Rodrigo Correa-Oliveira; Nicola A Bailey; Nejat K Egilmez; Edith Mathiowitz; Philip T LoVerde
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Lipid core peptide targeting the cathepsin D hemoglobinase of Schistosoma mansoni as a component of a schistosomiasis vaccine.

Authors:  Annette M Dougall; Mariusz Skwarczynski; Makan Khoshnejad; Saranya Chandrudu; Norelle L Daly; Istvan Toth; Alex Loukas
Journal:  Hum Vaccin Immunother       Date:  2013-11-14       Impact factor: 3.452

Review 9.  Structure-function analysis of apical membrane-associated molecules of the tegument of schistosome parasites of humans: prospects for identification of novel targets for parasite control.

Authors:  Chiuan Yee Leow; Charlene Willis; Andreas Hofmann; Malcolm K Jones
Journal:  Br J Pharmacol       Date:  2014-12-23       Impact factor: 8.739

10.  Transcriptional changes in Schistosoma mansoni during early schistosomula development and in the presence of erythrocytes.

Authors:  Geoffrey N Gobert; Mai H Tran; Luke Moertel; Jason Mulvenna; Malcolm K Jones; Donald P McManus; Alex Loukas
Journal:  PLoS Negl Trop Dis       Date:  2010-02-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.